article thumbnail

Top Cardiology Conferences in 2025

Cardiology Update

As we step into 2025, the field of cardiology continues to offer exciting opportunities for knowledge exchange and networking at in-person conferences. Here is a preview of the upcoming cardiology conferences planned for 2025. Important Deadlines: Early registration fee: January 14, 2025.

article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

tim.hodson Fri, 03/14/2025 - 11:42 March 11, 2025 CareDx, Inc. Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. 5 As with other organ transplants, the organs are at risk of rejection.

article thumbnail

Deucravacitinib Improves PsA Symptoms and Quality of Life in POETYK PsA-2

HCPLive

Data from the POETYK PsA-2 trial examining deucravacitinib were presented at the 2025 American Academy of Dermatology annual meeting.

article thumbnail

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

tim.hodson Tue, 02/18/2025 - 10:08 Feb. 13, 2025 Research from Cedars-Sinai investigators and collaborators at other leading medical institutions is helping to provide more treatment options to people living with tricuspid valve disease. Image by Getty. When might a minimally invasive procedure be the best approach?

article thumbnail

New Tool Helps Predict Stroke Outcome with Higher Accuracy

DAIC

tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.

Strokes 52
article thumbnail

Study Shows Medtronic ICM Accurately Predicts Risk Thresholds for AFib Patients Using AI

DAIC

tim.hodson Wed, 01/29/2025 - 13:02 Jan. The results were presented at the AF Symposium 2025. ii The DEFINE AFib clinical study enrolled 973 patients using an app-based enrollment feature and characterized the impact of AF burden on patient outcomes and quality of life. By 2030, approximately 12.2

AFIB 52
article thumbnail

GOLD 2025 Report: Dupilumab, a New Treatment in COPD

HCPLive

Panelists discuss how the BOREAS and NOTUS phase 3 trials demonstrated that dupilumab significantly reduced exacerbations, improved lung function, and enhanced quality of life in patients with uncontrolled chronic obstructive pulmonary disease (COPD), particularly those with elevated eosinophil counts, highlighting its potential in targeted therapy. (..)